Classys Highlights Cartessa Partnership at 2025 J.P. Morgan Healthcare Conference
Classys, Inc. recently spoke at the 2025 J.P. Morgan Healthcare Conference, highlighting their long-term growth and expansion plans in the U.S. and Europe, including their new partnership with Cartessa to bring EVEREVESSE by Volnewmer to the U.S. market. Below is an excerpt from Classys Details US Expansion and European Launch Plans at JPM2025, as seen in Korea Biomedical Review.
Korean aesthetics company Classys announced plans at the J.P. Morgan Healthcare Conference in San Francisco on Thursday to expand into the U.S. and European markets with its flagship devices, Shurink Universe and Volnewmer.
In the U.S., Volnewmer, rebranded as EVERESSE, has been introduced to key opinion leaders (KOLs) to build early adoption. These medical professionals are expected to promote the device to broader networks of clinics and hospitals.
According to Classys, KOLs who have already integrated the product into their practices are satisfied with its performance and are expected to recommend it to peers, facilitating wider adoption.
Classys finalized a distribution agreement in October with U.S.-based Cartessa Aesthetics, a leading distributor of aesthetic medical devices, and anticipates significant sales growth beginning in 2025. The Classys official emphasized that the U.S. market is "no longer a distant goal for the company but a well-structured plan already in motion."